TruBridge, Inc.
NASDAQ:TBRGMedical - Healthcare Information Services
+$0.00 today
- Market cap
- $393.58M
- Beta
- 1.29
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.30
Volume 0.30M
Average 0.31M
TBRG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
TruBridge, Inc.NASDAQ: TBRG
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development dips below year-ago levels
Q1 FY2026 research & development of $7.45M fell 9.7% year over year, behind the +24.6% change in trailing-twelve-month research & development. Sequentially, it fell 6.7% from the prior quarter. Over 3 fiscal years it compounded at +1.7% a year.
Context
- Research & development amounted to 9.4% of revenue in FY2025, down 0.7 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -9.7% toward the trailing-twelve-month pace of +24.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 32.56M USD
- Year-over-year change
- -5.5%
- 4-year CAGR
- +1.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 32.56M | -5.5% |
| FY2024 | 2024-12-31 | 34.46M | -7.5% |
| FY2023 | 2023-12-31 | 37.25M | +20.4% |
| FY2022 | 2022-12-31 | 30.93M | +1.8% |
| FY2021 | 2021-12-31 | 30.39M | — |
Research & Development vs competitors
How TBRG compares with its peers on the latest reported figures
- TBRG's LTM Mar 2026 research & development of $39.88M is the 2nd highest of the 11 companies compared; the peer median is $13.23M.
- Its year-over-year change of +24.6% is the 3rd highest of 10, against a peer median of +5.3%.
- Research & development amounts to 11.5% of revenue for TBRG, versus a peer median of 12.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $65.65M | +7.6% | +0.8% | 29.5% | |
| LTM Mar 2026 | $39.88M | +24.6% | +1.7% | 11.5% | |
| LTM Mar 2026 | $35.89M | +5.3% | -1.7% | 44.2% | |
| LTM Mar 2026 | $32.9M | -13.4% | -7.3% | 80.8% | |
| LTM Mar 2026 | $31.97M | -10.4% | -0.1% | 13.4% | |
| LTM Mar 2026 | $13.97M | -23.1% | -7.7% | 24.2% | |
| LTM Mar 2026 | $12.5M | +7.2% | -3.9% | 9.1% | |
| LTM Feb 2026 | $9.34M | +29.5% | +29.0% | 11.6% | |
| LTM Mar 2026 | $7.53M | -25.4% | +35.2% | 3.4% | |
| LTM Mar 2026 | $3.48M | +1276.3% | — | 3.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TBRG) | $13.23M | +5.3% | -0.9% | 12.5% | |
Competitors are the stored peer set for TBRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 280.63M | 326.65M | 339.44M | 342.65M | 346.84M |
| Cost of Revenue | 135.78M | 166.54M | 175.87M | 168.53M | 162.97M |
| Gross Profit | 144.85M | 160.11M | 163.57M | 174.12M | 183.86M |
| Gross Margin | 51.6% | 49.0% | 48.2% | 50.8% | 53.0% |
| Research & Development | 30.39M | 30.93M | 37.25M | 34.46M | 32.56M |
| Selling, General & Admin | 70.46M | 82.1M | 104.2M | 104.05M | 104.2M |
| Operating Expenses | 120.14M | 137.32M | 206.17M | 167.48M | 163.03M |
| Depreciation & Amortization | 16.87M | 23.33M | 26.47M | 28.97M | 26.28M |
| EBITDA | 43.11M | 47.73M | (15.39M) | 34.94M | 42.46M |
| EBITDA Margin | 15.4% | 14.6% | -4.5% | 10.2% | 12.2% |
| Operating Income | 24.71M | 22.78M | (42.6M) | 6.64M | 20.83M |
| Operating Margin | 8.8% | 7.0% | -12.6% | 1.9% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.16M | 6.32M | 12.52M | 16.17M | 12.32M |
| Other Income / Expenses | (1.63M) | (4.7M) | (11.78M) | (16.84M) | (16.96M) |
| Income Before Tax | 23.08M | 18.08M | (54.38M) | (10.2M) | 3.87M |
| Pre-Tax Margin | 8.2% | 5.5% | -16.0% | -3.0% | 1.1% |
| Income Tax Expense | 4.65M | 2.21M | (8.59M) | 10.24M | (485K) |
| Net Income | 18.43M | 15.87M | (45.79M) | (20.44M) | 4.35M |
| Net Margin | 6.6% | 4.9% | -13.5% | -6.0% | 1.3% |
| EPS (Basic) | 1.26 | 1.08 | (3.15) | (1.38) | 0.29 |
| EPS (Diluted) | 1.26 | 1.08 | (3.15) | (1.38) | 0.29 |
| Weighted Avg Shares | 14.29M | 14.36M | 14.19M | 14.3M | 14.49M |
| Weighted Avg Shares (Diluted) | 14.32M | 14.36M | 14.19M | 14.3M | 14.49M |
TruBridge, Inc.
NASDAQ:TBRG
Intrinsic Alpha fair value
Locked
Current Price
$26.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.